DDW 2024
Study Finds GLP-1s Safe and Effective For Managing Obesity in Patients With IBD
GLP-1s are well tolerated and effective for weight loss in patients with IBD, according to new research
NOVEMBER 6, 2024
Machine Learning Can Predict Best Responders to GLP-1s
Machine learning tools can sift through genetic profiles to predict which patients with obesity will best respond ...
SEPTEMBER 20, 2024
Long-Acting Apraglutide Reduces Need for Parenteral Support
Apraglutide reduces the need for parenteral nutrition in people with intestinal failure due to short bowel ...
SEPTEMBER 18, 2024
FIT Reduces Deaths From Colorectal Cancer
Evidence is emerging for the power of fecal immunochemical testing to not only reduce colorectal cancer incidence ...
AUGUST 21, 2024
Survodutide Shows Significant Improvement in MASH and Liver Fibrosis in Phase 2 Trial
Patients taking the glucagon/glucagon-like peptide-1 receptor dual agonist survodutide saw an 83% improvement in ...
AUGUST 9, 2024
Data From Wearables Can Indicate Flares in Patients With IBD
Data collected by wearables, such as an Apple Watch, Fitbit or Oura Ring, can help uncover flares in people with UC ...
AUGUST 6, 2024
